| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Lantheus Holdings, Inc | $6.5b | $100.97 | -1.8% | 746.3K | |
| Immunome, Inc. | $2.5b | $18.56 | -5.7% | 895.7K | |
| AbCellera Biologics Inc. Common Shares | $1.9b | $5.61 | -11.9% | 8.9M | |
| Aktis Oncology, Inc. Common stock | $1.1b | $18.88 | -5.1% | 138.6K | |
| Alpha Tau Medical Ltd. Ordinary Shares | $1.0b | $9.36 | -9.0% | 1.4M | |
| Crescent Biopharma, Inc. Common Stock | $0.6b | $18.11 | -1.8% | 192.6K | |
| Perspective Therapeutics, Inc. | $449.3m | $3.03 | -6.8% | 1.9M | |
| PLUS THERAPEUTICS, Inc. Common Stock | $40.1m | $5.38 | -6.3% | 120.4K | |
| Actinium Pharmaceuticals, Inc | $39.5m | $1.08 | -2.7% | 197.1K | |
| American Shared Hospital Services | $9.7m | $1.33 | -3.6% | 119.4K | |
| iTonic Holdings Ltd Class A Ordinary Shares | $5.1m | $0.28 | -6.3% | 39.5K |